Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261
[email protected]

Presentations & Publications

Science underlying Inspirna’s pipeline has been published in leading scientific journals and presented at renowned medical conferences.

Ompenaclid (RGX-202)

Abequolixron (RGX-104)


Discovery Platform